Release Date: 31/01/23 14:53 Summary: Quarterly Activities/Appendix 5B Cash Flow Report Price Sensitive: Yes Download Document 3.58MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%